Drug Profile
TY 51184
Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Toa Eiyo
- Class
- Mechanism of Action Chymase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Post-surgical adhesions
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Post-surgical-adhesions in Japan (Topical, Irrigation)
- 31 Jan 2008 Preclinical development is ongoing
- 03 Nov 2003 TY 51184 is available for licensing (http://www.toaeiyo.co.jp/)